There is a striking resemblance between the hematologic changes seen in mice in whom NO-cGMP signaling was activated, either by NO inhalation or sGC overexpression, and the hematologic response of SCD patients undergoing HU therapy (Figs 1–3). This evidence concerns the gene SGCB and Schnyder corneal dystrophy.